Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: A report from the children's oncology group

Pediatric Blood and Cancer

Volumn 52, Issue 2, 2009, Pages 254-258

  Fernandez, Conrad V ^a,h   Anderson, James ^b   Breslow, Norman E ^c   Dome, Jeffrey S ^d   Grundy, P E ^e   Perlman, Elizabeth J ^f   Green, Daniel M ^g  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f CHILDREN'S MEMORIAL HOSPITAL   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^h IWK HEALTH CENTRE   (Canada)

Author keywords

Body mass index; Prognosis; Wilms

Indexed keywords

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CHILD; CHILDHOOD CANCER; CHROMOSOME 16Q; CHROMOSOME 1P; CLINICAL TRIAL; CONTROLLED STUDY; EVENT FREE SURVIVAL; FOLLOW UP; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEPHRECTOMY; NEPHROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; AGE; CHROMOSOME 1; CHROMOSOME 16; DISEASE FREE SURVIVAL; GENETICS; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY;

AGE FACTORS; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 16; DISEASE-FREE SURVIVAL; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; NEPHRECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; WILMS TUMOR;

EID: 59449105203     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21809     Document Type: Article

References (27)

1. Breslow N, Sharples K, Beckwith JB, et al. Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 1991;68:2345-2353.
2. Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 2005;23:7312-7321.
3. Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005;293:203-211.
4. Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: A multivariate analysis. Arch Dis Child 1994;71:304-310.
5. Hijiya N, Panetta JC, Zhou Y, et al. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 2006;108:3997-4002.
6. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
7. Lahorra JM, Ginn-Pease ME, King DR. The prognostic significance of basic anthropometric data in children with advanced solid tumors. Nutr Cancer 1989;12:361-369.
8. Wessels G, Hesseling PB, Van Ommeren KH, et al. Nutrition, morbidity, and survival in South African children with Wilms' tumor. Pediatr Hematol Oncol 1999;16:321-327.
9. Donaldson SS, Wesley MN, DeWys WD, et al. A study of the nutritional status of pediatric cancer patients. Am J Dis Child 1981;135:1107-1112.
10. Statistics. CNCfH; 5 June 2008. gc-calculate-BIV.sas. http://www.cdc.gov/nccdphp/dnpa/growthcharts/sas.htm. [Accessed 5 June 2008].
11. National Center for Health Statistics. CDC. Clinical Growth Charts. http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical-charts.htm. [Last accessed 5 June 2008].
12. Petruzzi MJ, Green DM. Wilms' tumor. Pediatr Clin North Am 1997;44:939-952.
13. Breslow NE, Beckwith JB, Perlman EJ, et al. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer 2006;47:260-267.
14. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861-1867.
15. Flegal KM, Graubard BI, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298:2028-2037.
16. Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: The International Breast Cancer Study Group experience. Ann Oncol 2004;15:875-884.
17. Bastarrachea J, Hortobagyi GN, Smith TL, et al. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994;120:18-25.
18. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003;98:484-495.
19. Meloni G, Proia A, Capria S, et al. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transpl 2001;28:365-367.
20. Fleming DR, Rayens MK, Garrison J. Impact of obesity on allogeneic stem cell transplant patients:Amatched case-controlled study. Am J Med 1997;102:265-268.
21. Rickard KA, Godshall BJ, Loghmani ES, et al. Integration of nutrition support into oncologic treatment protocols for high and low nutritional risk children with Wilms' tumor. A prospective randomized study Cancer 1989;64:491-509.
22. Yeazel MW, Ross JA, Buckley JD, et al. High birth weight and risk of specific childhood cancers: A report from the Children's Cancer Group. J Pediatr 1997;131:671-677.
23. Leisenring WM, Breslow NE, Evans IE, et al. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res 1994;54:4680-4683.
24. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: Pathophysiology, consequences, prevention, and treatment. Circulation 2005;111:1999-2012.
25. Blouin RA, Kolpek JH, Mann HJ. Influence of obesity on drug disposition. Clin Pharm 1987;6:706-714.
26. Rodvold KA, Rushing DA, Tewksbury DA. Doxorubicin clearance in the obese. J Clin Oncol 1988;6:1321-1327.
27. Mauer AM, Burgess JB, Donaldson SS, et al. Special nutritional needs of children with malignancies: A review. JPEN J Parenter Enteral Nutr 1990;14:315-324.